Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Mesothelioma Malignant Advanced”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Large-scale testing (Phase 3)Study completedNCT00128102
What this trial is testing

Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)

Who this might be right for
MesotheliomaLung Cancer
Merck Sharp & Dohme LLC 661
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT00017186
What this trial is testing

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 69
Early research (Phase 1)Study completedNCT00535951
What this trial is testing

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Who this might be right for
Carcinoma, Non-Small-Cell LungMesothelioma
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00541073
What this trial is testing

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Centre Oscar Lambret 60
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)Ended earlyNCT00003508
What this trial is testing

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Who this might be right for
Malignant Mesothelioma
Burzynski Research Institute 8
Testing effectiveness (Phase 2)UnknownNCT05598268
What this trial is testing

T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorLung CancerLiver Cancer+2 more
ImmVira Pharma Co. Ltd 74
Early research (Phase 1)Looking for participantsNCT05568680
What this trial is testing

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Who this might be right for
Ovarian CancerCholangiocarcinoma RecurrentMesothelioma, Malignant
Verismo Therapeutics 42
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Large-scale testing (Phase 3)Study completedNCT02991482
What this trial is testing

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 144
Testing effectiveness (Phase 2)UnknownNCT04713761
What this trial is testing

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China 15
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Large-scale testing (Phase 3)Study completedNCT00075699
What this trial is testing

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Medical Research Council 840
Early research (Phase 1)Ended earlyNCT04173338
What this trial is testing

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Who this might be right for
Non Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerUrothelial Carcinoma+1 more
Augusta University 9
Next Page